Dr Cleaversmith brings more than 17 years of experience in aquaculture and comes to CATC from Nevis Marine, where he provided consultancy services to the aquaculture industry, most notably as an industry expert with Hatch, an innovative aquaculture accelerator supporting a cohort of 13 technology companies on three different continents.
“I’m delighted to be joining the CATC team at such a pivotal moment in their growth. I look forward to working with the team, their customers, and stakeholders, in order to realise their ambitions to become a highly respected global player in the health and nutrition contract research space,” said Dr Cleaversmith
A graduate of Edinburgh University and the University of Glasgow, Dr Cleaversmith’s extensive expertise in aquaculture management spans two continents. He has served as AKVA Group Scotland’s, managing director and was also the operations and business development director at the Scottish Aquaculture Innovation Centre.
No stranger to Prince Edward Island, Dr Cleaversmith was the head of Novartis Aqua Health overseeing manufacturing and R&D in four facilities with a team of more than 125. Prior to joining Novartis, he led the bioscience portfolio on behalf of the Province of Prince Edward Island as senior investment manager.
Among many other career achievements, he is a fellow of the Royal Society of Biology, the Chartered Management Institute, and a member of the Institute of Directors. He currently sits on the board of the University of Prince Edward Islands technology transfer office (Synapse) and on the Innovate UK Animal Sector Advisory Board.
“It is my pleasure to welcome Jason to our team and back to PEI,” said CEO Dr John Buchanan. “His extensive experience and leadership in global aquaculture will be invaluable as we grow our health and nutrition business unit providing contract and research services.”
